CATEGORIES

Lissun raises $2.5 M in Pre-Series A funding round

Gurugram-based mental healthcare startup Lissun has announced a successful Pre-Series A funding round, raising $2.5 million, marking a significant milestone in Lissun's continued growth and success.

Qure.ai completes $65 M Series D funding round

Mumbai-based startup Qure. ai, a global healthcare artificial intelligence (AI) innovator, has announced the completion of a $65 million Series D funding round.

Venture Center partners with UNIDO and BEE to strengthen technology transfer offices in India

Pune-based Venture Center, a leading technology business incubator for science-driven enterprises in India, has announced a partnership with the United Nations Industrial Development Organization (UNIDO) and the Bureau of Energy Efficiency (BEE) to support capacity-building efforts aimed at strengthening technology transfer offices in Indian institutions, to increase commercialisation of innovations.

Twist Bioscience teams up with MedGenome to diagnose rare diseases

To address the rare disease burden in India, Bengaluru-based MedGenome is partnering with Twist Bioscience, a leading and rapidly growing synthetic biology and genomics company based in the US, to establish the HOPE for Rare Diseases Programme in India.

Lupin partners with Celnova to commercialise orphan drug NaMuscla in Argentina and Colombia

Mumbai-based global pharma major Lupin has announced that its subsidiary Lupin Atlantis Holdings SA has entered into a distribution agreement with Celnova Pharma for Lupin’s orphan drug NaMuscla (mexiletine).

Neovantage Innovation Parks secures Rs 300 Cr for life sciences real estate portfolio

Neovantage Innovation Parks, South Asia’s largest private owner and operator of life sciences-focused real estate, has secured its inaugural green loan of Rs 300 crore from HSBC India.

Piramal Pharma Solutions announces $80 M expansion plan for sterile injectables facility in US

Mumbai-based Piramal Pharma Solutions (PPS), a leading global Contract Development and Manufacturing Organisation (CDMO) and part of Piramal Pharma, has unveiled an $80 million investment plan to expand its Lexington, Kentucky facility in the US.

PMBI and Coal India ink MoU to provide highquality generic medicines

In a significant milestone under the mission to provide quality generic medicines and surgical equipment at affordable prices to the masses, the Pharmaceuticals and Medical Devices Bureau of India (PMBI) and Coal India Limited (under the administrative control of the Ministry of Coal, Government of India) have signed a Memorandum of Understanding (MoU) for opening of Jan Aushadhi Kendras in the premises of every coal field, selected hospitals or any suitable location specified or decided by Coal India Limited.

Cabinet approves 'Bio-RIDE' scheme to support cutting edge biotech R&D

The Union Cabinet, chaired by the Prime Minister (PM) Narendra Modi, has approved continuation of the two umbrella schemes of Department of Biotechnology (DBT), merged as one scheme‘Biotechnology Research Innovation and Entrepreneurship Development (Bio-RIDE)’ with a new component namely Biomanufacturing and Biofoundry.

CDSCO becomes Affiliate Member of International Medical Device Regulators Forum

To achieve global alignment in its medical device regulatory system, enhance the competitiveness of the domestic industry, and boost transnational prominence, the Central Drugs Standard Control Organisation (CDSCO), under the Ministry of Health and Family Welfare, applied for Affiliate Membership in the International Medical Device Regulators Forum (IMDRF) in 2024.

Health Ministry releases revised operational guidelines for Non-Alcoholic Fatty Liver disease

The Union Health Ministry has released the revised Operational Guidelines and Training Module of Non-Alcoholic Fatty Liver Disease (NAFLD).

Can phased trade margin rationalisation boost pharma growth?

The pharma representatives of the Laghu Udyog Bharati (LUB), an RSS affiliate and a not-forprofit Pan India Organisation with the aim of empowering Micro and Small enterprises in the country since its formation in 1994, on July 24, had a meeting with officials from the Department of Pharmaceuticals, and discussed key issues such as Trade Margin Rationalisation (TMR), Schedule-M extension, Revised PTUS Hurdles, and the Drug Tribunal Board formation. LUB Pharma proposed the innovative \"One Nation-One Molecule-One MRP\" and advocated for the top 100 companies to sell their generic brands at molecule name and affordable Maximum Retail Price (MRP) for patient benefits. Here we are looking at a series of recommendations from industry associations to make TMR more effective, balanced, and supportive of all stakeholders in the pharmaceutical supply chain.

Why industry-academia collaboration is crucial for biomedical sciences

India's growing biomedical sciences sector is ripe with potential, yet it faces several challenges. In recent years, there has been a notable shift in government policies, private investments, and educational reforms aimed at boosting research and innovation in this critical area. One of the key factors that can significantly influence this growth is the collaboration between industry and academia. Such partnerships have the power to not only fuel the biomedical sector but also strengthen India's position as a global player in healthcare research and innovation.

Study reveals role of Ayurvedic Whole System in management of Rheumatoid Arthritis

A new scientific study has revealed the significant effectiveness of the Ayurvedic Whole System (AWS) in the management of Rheumatoid Arthritis (RA), a chronic autoimmune disorder affecting millions worldwide.

Amit Mookim steps in as CEO of Immuneel Therapeutics

Bengaluru-based Immuneel Therapeutics, a pioneering cell and gene therapy platform, has announced the appointment of Amit Mookim as its new Chief Executive Officer (CEO).

Meril expands healthcare education network with opening of Satellite Academy in Kochi

Meril, a global medical technology and education leader, has expanded its healthcare education network by launching the Meril Satellite Academy in Kerala’s port city, Kochi.

Skye Air Mobility partners with CARITAS Hospital for drone-based medical deliveries in Kottayam

New Delhi-based startup Skye Air Mobility, a leading drone technology-based logistics firm, has announced a collaboration with CARiTAS Hospital & Institute of Health Sciences, Kottayam, Kerala, to revolutionise medical deliveries through drone technology.

Pristyn Care partners with CureMyKnee to establish CoE for joint replacement surgeries

Gurugram-based startup Pristyn Care, a leading healthcare provider specialising in advanced secondary care surgeries, is establishing a Centre for Excellence (CoE) in Joint Replacement Surgeries with Cure My Knee.

Vipragen, Zumutor form strategic alliance in biologics CRO sector

Bengaluru-based companies Vipragen Biosciences and Zumutor Biologics have announced a strategic partnership to set up an endto-end Biologics Contract Research Organisation (CRO) platform to support discovery, clone to preclinical development of biologics/biosimilars.

Cambrian Bioworks raises $1.45 M to transform molecular diagnostics in India

Bengaluru-based biotechnology startup Cambrian Bioworks has secured $1.45 million in seed funding.

Health Minister introduces National Medical Register Portal of National Medical Commission

Union Minister for Health & Family Welfare, Jagat Prakash Nadda recently inaugurated the National Medical Register (NMR) Portal of the National Medical Commission (NMC) for registration of all the MBBS doctors who are eligible for registration in India, in presence of Union Minister of State (MoS) for Health & Family Welfare, Anupriya Patel and virtual presence of Union MoS for Health & Family Welfare, Prataprao Jadhav.

Centre launches National Strategy For Prevention of Unintentional Injury

The Ministry of Health and Family Welfare, Government of India and World Health Organization (WHO) released India's National Strategy For Prevention of Unintentional Injury at #Safety2024: 15th World Conference on Injury Prevention and Safety Promotion on September 2 in New Delhi.

"Bridge the gap and accelerate India's advancements in innovative therapies"

Dr Ramesh Mundlamuri has over 19 years of experience in various biopharmaceutical organizations and has ample experience in various divisions and sections of the biopharmaceutical industry, including Research & Development, Technology Transfer, Commercial Manufacturing, Product & Process Development, Operations Management and so on.

Bharat BioEconomy to touch.$30 trillion by 2050: IBER 2024

“The Indian BioEconomy is projected to rise to $30 trillion by 2050, within a global economy valued at $228 trillion, representing a significant increase in its economic share from 4 to 13 per cent,” according to the India BioEconomy Report (IBER 2024), prepared for 'Make In India Facilitation Cell for Biotechnology' of Biotechnology Industry Research Assistance Council (BIRAC), by Association of Biotechnology Led Enterprises (ABLE).

TELANGANA WAGES WAR AGAINST COUNTERFEIT DRUGS

Telangana contributes nearly one-third to India’s production and one-fifth to its exports in the pharmaceutical sector.

BHARAT EYES GLOBAL BIOMANUFACTURING DOMINANCE: Boosting Innovation, Collaboration & Entrepreneurship with BioE3 Policy

Bharat has demonstrated a strong economic growth in the past decade and is poised to be amongst the global leaders in the next industrial revolution by leveraging emerging technologies and new innovative solutions.

Economic Survey Lays Focus On Mental Healthcare For The First Time

For the first time ever, the Economic Survey 2023-24 tabled by the Union Minister of Finance and Corporate Affairs Nirmala Sitharaman in Parliament recently, talks extensively about mental health, its significance and implications on policy recommendations.

IIT-G discovers RNA-destroying function of p30 protein in African Swine Fever Virus

Indian Institute of Technology Guwahati (IIT-G) researchers have investigated the biochemistry of the African Swine Fever Virus (ASFV) protein, focusing on understanding the biochemical processes of infection to devise effective control strategies.

13th Bengaluru INDIA NANO 2024 brings together 1018 delegates, 3,000+ visitors

The 13th edition of Bengaluru INDIA NANO 2024, organised by the Department of Science & Technology, Government of Karnataka, Karnataka Science & Technology Promotion Society (KSTePS), and Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) concluded on August 3 with participation of 1018 delegates, 11 countries including Korea, Morocco, USA, UK, France, Canada, Germany, Netherlands, Russia, Japan, and Poland, 49 exhibitors comprising 21 startups and 28 industry and institutes, and 200 posters. The exhibition had a footfall of 3,000+ visitors.

Are Nutraceuticals DRUGS? Examining a Needless Regulatory Tussle

The news has been around for a while which has put a big question mark ahead of the Indian nutraceuticals industry.